What Everyone Ought to Know about Vulvovaginal Disease
Transcription
What Everyone Ought to Know about Vulvovaginal Disease
ANNUAL MEETING ASCCP2016 APRIL 13, 2016 HILTON NEW ORLEANS RIVERSIDE PRE-COURSE What Everyone Ought to Know about Vulvovaginal Disease www.asccp.org/2016annualmeeting 1 Meeting Information Meeting Competencies and Objectives The Vulvovaginal Disease course is for all clinicians dealing with women’s health. Although vaginal and vulvar complaints are common, many clinicians feel underprepared to deal with these issues. This one-day workshop will cover many aspects involving the diagnosis and treatment of these diseases • Upon completion of this educational activity and its post-test and evaluation tool, the learner should be able to: Continuing Medical Education ACCME Accreditation The American Society for Colposcopy and Cervical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. • Gain knowledge on vulvovaginal conditions and their management The ASCCP Pre-Course: What Everyone Ought to Know about Vulvovaginal Disease was planned and produced in accordance with the ACCME’s Essential Areas and Elements and Updated Criteria (see www.accme.org). • Understand the diagnosis and treatment of vulvodynia Continuing Medical Education Credits • Explore the current thoughts on squamous intraepithelial lesions, including diagnosis and treatment measures Attendees will receive a maximum of 6.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. • Gain knowledge on unusual vaginitis conditions Course Educational Methods Lectures: Each day, the learners will attend general plenary sessions related to their areas of interest. Each session will conclude with a question and answer period led by the presenter(s) to reinforce core concepts. Throughout the lectures and question and answer periods, faculty members utilize an Audience Response System. The faculty uses these group responses to readdress items not answered correctly by the target goal percentage. This immediate feedback helps course attendees identify their own weaknesses and allows them to follow up with the faculty onsite. Interactive Case Study Sessions: Several interactive sessions will be used throughout the course to test medical knowledge and practice-based learning skills on various vulvar, vaginal and cervical conditions. Participants, in conjunction with faculty leadership, will review cases, vote on their diagnosis and discuss what management and treatment course they would pursue and why. Panel Discussions: For selected topics, learners will direct questions to panels of experts on how to integrate reported advances into their practices. Experts will present their varying evidence-based perspectives so that learners can determine what may be best practice in their setting. The lectures will be available for download until May 16, 2016 at www.asccp.org/2016annualmeeting/VDlectures 2 Instructions for Obtaining Continuing Medical Education Credit To complete this program successfully and receive credit and a certificate of attendance, participants must: • Complete the pre-test found online prior to the meeting; • Read the program educational objectives and review and utlize the final program; • Sign in at the ASCCP registration desk and attend the program; • Complete the post-test and post-conference assessment (15 minute online survey); • Claim credits via ASCCP webpage CME Certificates CME certificates will be available online after completion of the evaluation. During the meeting, if you notice an error on your name badge, registration letter, or any other ASCCP materials, please stop by the registration desk so that we may correct. Management of Disclosure of Interest and Contributed Fund COI Disclosure Key As an accredited provider of CME credit, ASCCP is required to comply with the ACCME’s Standards for Commercial Support and has implemented a management process to ensure that anyone who is in a position to affect the content of the educational activity (e.g., faculty, planners, etc.) has disclosed to us all relevant financial relationships with any commercial interest and has ensured that those relationships do not influence presentation materials. All faculty have agreed to base their presentations on best available evidence. ASCCP discloses to learners any financial relationship(s) to healthcare-related commercial interests existing within the past 12 months to include the following information: 1) the name of the individual; 2) the name of the commercial interest; and, 3) the nature of the relationship the person has with each commercial interest. Program directors review presentation materials for possible bias prior to the program, and potential conflicts of interest are resolved prior to the presentation. Any discussion of off-label use of products is noted when appropriate, as is discussion of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Disclosures of these commitments and/or relationships are published in the final program materials and provided from the podium so those participants in the activity may formulate their own judgments regarding the presentation(s). The program directors and co-directors also monitor presentations for bias and intervene as appropriate to provide balance. Under ASCCP policy, anyone declining either to disclose or amend material to eliminate potential bias identified by the program directors are replaced. Medical Advisor (A) Advisory Board (AB) Book Author or CD Author (BA) Book Editor (BE) Clinical Trial Pathologist (CTP) Clinical Trial Support (CTS) Clinical Trial Consultant (CTC) Consultant (C) Consulting Medical Director (CMD) Consulting Pathologist (CP) Data Steering Committeee (DSM) Dividends (D) Educational Grant (EG) Equipment Support (E) Employee (EM) Fee (F) General Support (G) Stockholder (SH) Sub-investigator (SI) Travel (T) Tumor Bank QC Review (TBR) Vaccine Advisory Committee (VAC) Honorarium received (H) International Symposium Speaker (ISS) Invention (I) Licensed Patent (LP) Medical Advisory Board (MAB) Principle Investigator (PI) Quality Assurance Review (QAR) Research (RE) Research Grant (RG) Research Support (RS) Royalty (R) Salary (S) Scientific Advisory Board (SAB) Slide Adjudication Panel (SAP) Speaker’s Bureau (SB) Speaker’s Bureau Advisor (SBA) Stockholder (SH) Sub-investigator (SI) Travel (T) Tumor Bank QC Review (TBR) Vaccine Advisory Committee (VAC) Data and Safety Monitoring Board (DSMB) Study Consultant (SC) The disclosures listed below are all reported disclosures of interest or potential conflicts from the 12 months preceding this activity: 2016 AM COI Disclosures (Faculty, Program Directors, Education Committee Chairs, Staff) Jeff Andrews, MD (Editor-In-Chief) - No financial relationships or conflict of interest to disclose Kevin A. Ault, MD (Education Committee Chair) - Hologic (CTS) (PI); Merck & Co, Inc (CTS) (PI); Roche (CTS) (PI) Lilly Brotons (Staff) - No financial relationships or conflict of interest to disclose Kerry O. Curtis (Staff) - No financial relationships or conflict of interest to disclose Lisa M. DeGrave (Staff) - No financial relationships or conflict of interest to disclose Kathleen P.L. Dwyer (Staff) - No financial relationships or conflict of interest to disclose Hope K. Haefner, MD (Course Director & Faculty) - Merck (AB) Robin Heine (Staff) - No financial relationships or conflict of interest to disclose Beth C. Huff, MSN, FNP (Education Committee Chair) - No financial relationships or conflict of interest to disclose Sarah Jones (Staff) - No financial relationships or conflict of interest to disclose Chanise Queen (Staff) - No financial relationships or conflict of interest to disclose Cynthia A. Rasmussen, MD (Course Director & Faculty) - Pfizer Corp. (SH) Kimberly Sabatano (Staff) - No financial relationships or conflict of interest to disclose Colleen K. Stockdale, MD, MS (Program Director) - No financial relationships or conflict of interest to disclose Aruna Venkatesan, MD (Faculty) - No financial relationships or conflict of interest to disclose Alisha Yocum (Staff) - No financial relationships or conflict of interest to disclose What Everyone Ought to Know about Vulvovaginal Disease Program Wednesday, April 13, 2016 All sessions will take place in Grand Salon A unless otherwise noted. 7:00 AM - 8:00 AM Registration Foyer Grand Salon Breakfast Grand Ballroom A 8:00 AM - 8:15 AM Welcome Speakers: Hope K. Haefner, MD Cynthia A. Rasmussen, MD 8:15 AM - 8:45 AM Overview of Vulvar Dermatology Speaker: Aruna Venkatesan, MD 8:45 AM - 9:15 AM Recurrent Vaginal Candidiasis, Bacterial Vaginosis, and Trichomonas Speaker: Cynthia A. Rasmussen, MD 9:15 AM - 9:35 AM Desquamative Inflammatory Vaginitis Speaker: Hope K. Haefner, MD 4 9:35 AM - 10:00 AM Questions and Faculty Responses 10:00 AM - 10:30 AM Break Grand Ballroom A 10:30 AM - 11:00 AM Ulcers :STDs, Immunoblistering diseases & aphthous ulcers. Speaker: Aruna Venkatesan, MD 11:00 AM - 11:30 AM The Lichens: Sclerous, Simplex Chronicus, and Planus Speaker: Cynthia A. Rasmussen, MD 11:30 AM - 11:50 AM Vaginal Dilation Speaker: Hope K. Haefner, MD 11:50 AM - 12:15 PM Questions and Faculty Responses 12:15 PM - 1:15 PM Lunch Grand Ballroom A 1:15 PM - 1:45 PM Puzzling Cases Speakers: Hope K. Haefner, MD Cynthia A. Rasmussen, MD Aruna Venkatesan, MD 1:45 PM - 2:15 PM Genitourinary Syndrome of Menopause 1:45 PM - 2:00 PM Atrophy Speaker: Cynthia A. Rasmussen, MD Course Directors Hope K. Haefner, MD 2:00 PM - 2:15 PM Fissures Speaker: Aruna Venkatesan, MD University of Michigan Medical Center Ann Arbor, MI 2:15 PM - 2:45 PM Hidradenitis Suppurativa and Crohn’s Disease of the Vulva Speaker: Hope K. Haefner, MD Cindy Rasmussen, MD 2:45 PM - 3:15 PM Questions and Faculty Responses 3:15 PM - 3:45 PM Break Grand Ballroom A 3:45 PM - 4:15 PM Puzzling Cases Speakers: Hope K. Haefner, MD Cynthia A. Rasmussen, MD Aruna Venkatesan, MD 4:15 PM - 4:30 PM Questions and Faculty Responses 4:30 PM Adjourn Harvard Vanguard Medical Center Burlington, MA Speaker Aruna Venkatesan, MD Santa Clara Valley Medical Center/ Stanford University San Jose, California 5 Hotel Floor Plan Grand Ballroom A First Level RIVERFRONT STREETCAR DEPOT GRAND BALLROOM BURGUNDY LE CROISSANT A N FRONT ENTRANCE TO MAIN LOBBY POYDRAS STREET CONCIERGE 1ST FLOOR REGISTRATION COUNTERS GUEST ROOM ELEVATORS C D S GIFT SHOP SIDE DRIVE WORLD TRADE CENTER PARKING GARAGE CHEMIN ROYALE 1 4 7 10 13 16 19 22 2 5 8 11 14 17 20 23 3 6 9 12 15 18 21 24 GRAND SALON CONVENTION CENTER BLVD. Grand Salon A 6 B TO CONVENTION CENTER ASCCP Courses Comprehensive Colposcopy High Resolution Anoscopy Beginning/intermediate colposcopist or those in needs of updates—Gain additional knowledge on Cervical Cancer Screening & Management Guidelines, new concepts about HPV screening and triage, treatment methods, and HPV epidemiology. This course is for those participating in the health care of patients who have increased risk for anal cancer including MSM, men and women with HIV disease, and women with HPV-associated lower genital tract disease. July 27-30, 2016 Providence, RI July 28-30, 2016 Providence, RI October 26-29, 2016 Phoenix, Arizona For more information and to register go to www.asccp.org ASCCP Colposcopy Mentorship Program (CMP) Earn Your Certificate of Completion in Colposcopy— Sign-Up Today! www.asccp.org 7 Save the Date! IFCPC 2017 World Congress for Cervical Pathology and Colposcopy April 4-7, 2017 | Orlando, Florida www.ifcpc2017.com Hosted by ASCCP 8
Similar documents
Annual Meeting Program - American Society for Colposcopy and
Clinical Trial Pathologist (CTP) Clinical Trial Support (CTS) Clinical Trial Consultant (CTC) Consultant (C) Consulting Medical Director (CMD) Consulting Pathologist (CP) Data Steering Committeee (...
More information